期刊文献+

精神分裂症患者社会功能的影响因素 被引量:7

原文传递
导出
摘要 随着治疗技术的不断进展,促进精神分裂症患者社会功能的康复、回归社会,已经成为现代精神分裂症治疗的最终目标。但影响社会功能的因素较为复杂,我们选用多项检测注意、执行功能、心理运算能力的神经心理测量工具,以及临床精神症状及社会功能的评估量表,探讨影响精神分裂症社会功能的闪素,从而为更有效地提高患者社会功能提供参考。
出处 《中华精神科杂志》 CAS CSCD 北大核心 2011年第2期126-126,共1页 Chinese Journal of Psychiatry
基金 国家自然科学基金资助项目(30670757) “十一五”国家科技支撑项目(2007BA117B04)
  • 相关文献

参考文献3

  • 1Addington J, Girard TA, Christensen BK, et al. Social cognition mediates illness-related and cognitive influences on social function in patients with schizophrenia-spectrum disorders. J Psychiatry Neurnsei, 2010, 35: 49-54.
  • 2Kay SR, Opler LA., Lindenmayer JP. Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatry Res, 1988, 23:99-110.
  • 3司天梅,舒良,田成华,苏允爱,闫俊,程嘉,李雪霓,刘琦,马燕桃,张卫华,党卫民,张鸿燕.个体和社会功能量表中文版在精神分裂症患者中的信效度[J].中国心理卫生杂志,2009,23(11):790-794. 被引量:192

二级参考文献10

  • 1Hwu HG,Tan H,Chen CC,et al.Negative symptoms at discharge and outcome in schizophrenia[].Br J Psychi-atry.1995
  • 2Burns T,,Patrick D.Social functioning as an outcome measure in schizophrenia studies[].Acta PsychiatrScand.2007
  • 3Juckel G,Morosini PL.The new approach:psychosocial functioning as a necessary outcome criterion for therapeutic success in schizophrenia[].Current Opinion in Psychiatry.2008
  • 4Juckel G,Schaub D,Fuchs N,et al.Validation of the Personal and Social Performance(PSP)Scale in a German sample of acutely ill patients with schizophrenia[].Schizophrenia Research.2008
  • 5Patrick D,Morosini PL,Rothman M.Reliability,validity and sensitivity to change of the Personal and Social Per-formance scale in patients with acute schizophrenia[].International Journal of Neuropsychiatry.2006
  • 6Nasrallah H,Morosini P,Gagnon DD.Personal and So-cial performance scale in patients with stable schizophrenia[].Psychiatry Research.
  • 7Kane J,Canas F,Kramer M,et al.Treatment of schizo-phrenia with paliperidone extended-release tablets:a6-week placebo-controlled trial[].Schizophrenia Research.2007
  • 8Morosini,P. L.,Magliano,L.,Brambilla,L.,Ugolini,S.,Pioli,R.Development, reliability and acceptability of a new version of the DSM-IV social and occupational functioning assessment scale (SOFAS) to assess routine social functioning[].Acta Psychiatrica Scandinavica.2000
  • 9Kramer,M,Simpson,G,Maciulis,V,Kushner,S,Vijapurkar,U,Lim,P,Eerdekens,M.Paliperidone extended-release tablets for prevention of symptom recurrence in patients with schizophrenia: a randomized, double-blind, placebo-controlled study[].Journal of Clinical Psychopharmacology.2007
  • 10MARDER SR,KRAMER M,FORD L,et al.Efficacy and safetyof paliperidone extended-release tablets:Results of a 6-week,randomized,placebo controlled study[].Biological Psychiatry.2007

共引文献191

同被引文献47

  • 1赵福涛,徐淑敏,郭华.住院精神疾病患者精神用药情况调查分析[J].中国实用神经疾病杂志,2010,13(22):32-34. 被引量:6
  • 2王湘,姚树桥,樊旭辉,易运清,朱伟昂,蚁金瑶.缺陷型精神分裂症诊断量表中文版的信效度研究[J].中国临床心理学杂志,2005,13(4):392-395. 被引量:27
  • 3陈圣霞,魏春香,朱凤玲.阿立哌唑治疗精神分裂症临床观察[J].临床精神医学杂志,2006,16(1):46-47. 被引量:50
  • 4陈彦方.中国精神障碍分类与诊断标准.3版.济南:山东科技出版社,2001:45-50.
  • 5Carpenter WT, Buchanan RW. Lessons to take home from CAT- IE. Psyehiatr serv,2008,59 (5) :523-525.
  • 6McQuade RI), Bums KD, Jordan S, et al. Aripiprazo|e: a dopa- mine-serotomine systems stabilizer. Int J Neuro sycho-pharmacol, 2002,5 Suppl : 176.
  • 7Mossaheb N, Spindelegger C, Asensaum S, et al. Favourable re- suits in treatment-resistant schizophrenic patients under combina- tion of aripiprazole with clozapine. World J Biol Psychiatry ,2008, 29(1 ) :1-4.
  • 8Cipriani A, Boso M, Barbui C. Clozapinecombined with dittbrent antipsyehotie drugs for treatment resistant schizophrenia. Coehrane Database Syst Rev,2009,8(3 ) :324.
  • 9张明园.精神科评定量表手册[M]长沙:湖南科学技术出版社,1998163-166.
  • 10中华医学会精神科分会.中国精神障碍分类与诊断标准(CCMD-3)[M].第3版.济南:山东科学技术出版社,2001:57-78.

引证文献7

二级引证文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部